中国麻风皮肤病杂志 ›› 2017, Vol. 33 ›› Issue (12): 748-751,762.

• 综述 • 上一篇    下一篇

生物制剂治疗重度特应性皮炎研究进展

陈虹颖  陈旭  顾恒   

  1. 中国医学科学院皮肤病研究所，南京，210000
  • 出版日期:2017-12-15 发布日期:2018-12-13
  • 通讯作者: 顾恒，E-mail：guheng@aliyun.com

Update of biological agents in the treatment of moderate to severe atopic dermatitis

CHEN Hongying, CHEN Xu,GU Heng.   

  1. Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China
  • Online:2017-12-15 Published:2018-12-13
  • Contact: GU Heng, E-mail: guheng@aliyun.com

PDF (PC)

142

摘要： 长期系统应用糖皮质激素和免疫抑制剂治疗重度特应性皮炎副作用较大，生物制剂具有更高的安全性，本文就近年来生物制剂治疗重度特应性皮炎的研究进展作一综述。

关键词: 特应性皮炎, 生物制剂

Abstract: There are a lot of adverse effects of glucocorticoid and immunosuppressants in the treatment of moderate to severe atopic dermatitis (AD). Biological agents are more safe. The update of the biological agents in the treatment of AD is reviewed in this paper. 

Key words: atopic dermatitis, biological treatment